ANKIB1 & K11-Ubiquitin: Key to Innate Immunity & Disease Therapies
Researchers identified ANKIB1 and K11-ubiquitin as crucial regulators of innate immune signaling and interferon production. This discovery offers therapeutic potential for diverse diseases, including cancer, neurodegenerative conditions, and inflammatory disorders.